Lv1
58 积分 2024-06-13 加入
Promises and potential pitfalls of in vivo CAR gene therapy
17天前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
23天前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
1个月前
已完结
CD19 chimeric antigen receptor‐T cell therapy in murine immune thrombocytopenia
4个月前
已完结
FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model‐Based Assessments
8个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
8个月前
已完结
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
10个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
10个月前
已完结
Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis
1年前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1年前
已完结
皖公网安备34019202002308
